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ABSTRACT 
 
Topic: Study of changes in coagulation profile of patients undergoing laparoscopic 
cholecystectomy using carbon dioxide pneumoperitoneum 
 
 
Background: Laparoscopic cholecystectomy is a common surgical procedure and carbon 
dioxide pneumoperitoneum created for this purpose may alter the coagulation profile of 
these patients. This study aims to find the effects of carbon dioxide pneumoperitoneum 
on coagulation profile and assess if there is an increased risk of thrombosis. 
 
Materials and methods: A clinical observational study was conducted with 50 patients 
who underwent laparoscopic cholecystectomy using carbon di oxide pneumoperitoneum. 
The prothrombin time and D-dimer values were calculated before and after surgery .using 
the paired t test data was analyzed. 
 
Results: The study showed a decrease in the prothrombin time and increase in the D-
dimer value post operatively. The mean of prothrombin time after surgery was 0.13 
seconds lower than the preoperative value and D-dimer was found to be elevated three 
times the pre operative values. The p value calculated for both were highly significant. 
 
Conclusion: Laparoscopic cholecystectomy using carbon dioxide pneumoperitoneum 
leads to hypercoagulable states. Hence stringent measures need to be taken to put the 
patient on prophylaxis for deep vein thrombosis to avoid dire consequences   
 
Keywords: Laparoscopic  cholecystectomy, Carbon dioxide Pneumoperitoneum, 
Coagulation Profile, Prothrombin time, D-Dimer, Hypercoagulation, DVT prophylaxis 
 
 
 I 
 
TABLE OF CONTENTS 
   
 
 
S.NO TOPIC PAGE 
NUMBER 
1   INTRODUCTION 1 
2   AIM AND OBJECTIVES 3 
3   JUSTIFICATION 4 
4   BACKGROUND 5 
5   REVIEW OF LITREATURE 24 
6   STUDY PROTOCOL 47 
7   PROFORMA 55 
8   DATA ANALYSIS 58 
9   RESULTS 71 
10   DISCUSSION 74 
11   CONCLUSION 81 
12   LIMITATIONS 83 
13   BIBLIOGRAPHY i  
14   ANNEXURES ix 
15   MASTERCHART x 
 
 
 1 
 
 
 
  
INTRODUCTION 
 
                   Laparoscopy is one of the widely used tools for diagnostic and therapeutic 
purposes in recent times. Laparoscopy offers the advantage of better cosmesis, lesser 
post-operative pain, shorter hospital stay, early return to normal life and work. With 
advancements in technology and instrumentation, laparoscopy has entered into every 
array of surgical field.     
                
                  A working cavity is one of the requisites for laparoscopy. This cavity is 
commonly created by positive pressure pneumoperitoneum using carbon di oxide. In 
1924, Richard Zolliker of Switzerland first proposed the use of carbon di oxide for 
creation of pneumoperitoneum as it was noncombustible and hence electrocoagulation 
was possible during surgery. 
 
                   Carbon di oxide pneumoperitoneum affects normal physiology. It is easily 
absorbed from the peritoneal cavity into circulation. It may affect the cardiovascular, 
respiratory and coagulation system, to name a few. 
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                Laparoscopy has its complications due to increased intraabdominal pressure, 
carbon di oxide absorption from peritoneum during insufflation and reverse 
trendenlenberg position adopted during surgery. 
 
               The first laparoscopic cholecystectomy was performed in 1986 in Germany. 
Over the past 30 years there has been a gradual but drastic change in the methodology. 
The duration of surgery, complications have reduced over time. Laparoscopic 
cholecystectomy is now the gold standard procedure. And with over 5,00,000 procedures 
being done annually, laparoscopic cholecystectomy assumes a great significance in 
general surgical specialty.          
                                  
                 Effects of carbon di oxide pneumoperitoneum need to be studied in detail with 
respect to individual systems. This study aims to study the effects of carbon di oxide 
pneumoperitoneum on the coagulation system of patients undergoing laparoscopic 
cholecystectomy , and make the surgeon aware of the detrimental effects , if any. 
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AIM OF THE STUDY 
 
1.    To determine the changes in coagulation profile of patients undergoing 
laparoscopic cholecystectomy using carbon di oxide pneumoperitoneum. 
 
2.   Assess if there is an increased risk of thrombosis post-operatively. 
 
3.   To determine if patients undergoing laparoscopic cholecystectomy have to be 
started on prophylaxis for deep vein thrombosis to prevent complications. 
 
 
 
 
 
 
 
  
 4 
 
 
Reasons for conducting the study:  
 
1. Laparoscopic cholecystectomy is becoming more commonly used due to wider 
availability of facilities. 
 
2. No proper studies on effects of laparoscopic surgery using carbon di oxide 
pneumoperitoneum on coagulation system in India. 
 
3. To assess if there is an increase in the associated morbidity and mortality due to 
thrombotic phenomena. 
 
4. To assess if patients undergoing laparoscopic cholecystectomy surgeries are in 
need of prophylaxis against deep vein thrombosis. 
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Anatomy of  Gall bladder
1
:  
  The gall bladder is a pear or pyriform shaped organ that lies in close 
proximity to the liver(its inferior surface) . The gallbladder is divided anatomically into 
the fundus , body, infundibulum and the neck. The gallbladder opens into the cystic duct , 
through which bile enters and exits the gallbladder into the common bile duct. 
     The arterial supply of the gallbladder is by the cystic artery, which is a 
branch of the right hepatic artery. The venous drain is through the cystohepatic veins, 
These are multiple in number and are unnamed. Lymphatic drainage is mainly through 
the lymph node of Lund. Parasympathetic supply is through the right vagus and 
sympathetic through T7-9. 
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  The Calot’s triangle forms an important landmark for performing 
cholecystectomy, for it is here that both the cystic duct and cystic artery are ligated and 
cut. The Calot’s triangle is formed medially by the common hepatic duct superiorly by 
the inferior liver surface and the cystic duct laterally and inferiorly. 
                                  
The contents of the Calot’s triangle are the cystic artery and the lymph node of Lund. The 
normal volume of gallbladder varies from 30-50ml. but in cases of obstruction the size 
may increase manifold. The gallbladder is usually not palpable. A palpable gall bladder 
could mean an obstructive pathology in the common bile duct or rarely the cystic duct 
itself.   
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CHOLECYSTECTOMY: 
 
Cholecystectomy is the surgical removal of gall bladder. Indications
2 
 include 
symptomatic gall stones, gall bladder polyps greater than 1 cm, acute and chronic 
cholecystitis, acalculous cholecystitis, empyema gall bladder, mucocoele of gall bladder, 
typhoid carriers and gallstone pancreatitis.  
 
Prophylactic cholecystectomy is done in diabetic patients, immunocompromised patients, 
patients undergoing organ transplant, congenital hemolytic anemia, patients undergoing 
bariatric surgery and porcelain gall bladder. 
 
Absolute Contraindications of laparoscopic cholecystectomy include patients unfit for 
general anesthesia, patients with coagulation disorders, suspected gall bladder carcinomas 
as it might cause port site metastasis, and patients unwilling for laparoscopic procedure. 
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Relative contraindications are previous upper abdominal surgeries due to dense 
adhesions, liver cirrhosis as the liver is too brittle for retraction, portal hypertension as 
there may be multiple venous collaterals, patients with cardiac or respiratory 
complications and pregnancy. 
 
Problems associated with cholecystectomy may range from difficult Calot’s dissection, 
dense adhesions, perioperative bleeding from the pedicle or liver bed, anomalies of cystic 
duct and cystic artery may also pose a challenge. 
 
Complications after cholecystectomy include infection and sub phrenic abscess, bleeding 
from the cystic artery and liver bed. The common bile duct or the hepatic duct may get 
injured inadvertently. A bile leak or a biliary fistula or a stricture formation are some rare 
but serious complication. Iatrogenic injury to colon , duodenum or mesentery may occur 
in presence of dense adhesions.    
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HISTORY OF LAPAROSCOPIC CHOLECYSTECTOMY
3,4
 
 
1882-   Carl Langbuch from Germany performs the first cholecystectomy. 
1980-   Semm performs first laparoscopic appendectomy. 
1984-   Erich Muhe designs the galloscope (laparoscope for cholecystectomy) 
1985-   Sept12 – Erich Muhe performs the first laparoscopic cholecystectomy. 
              Uses pistol grip scissors, pistol grip applier and hemoclips. 
              Uses Verres technique to create pneumoperitoneum. 
1986-   Muhe presents the case before the German Surgical society and is rejected    
             by them. 
1987-   Lyon performs his first laparoscopic cholecystectomy in France. 
1988-   First laparoscopic cholecystectomy in USA.  
1990-   Perissat, Dubios, Cushieri acknowledged by SAGES for having performed  
            Laparoscopic Cholecystectomy 
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1992-   Muhe receives GSS anniversary award as acknowledgement for his   
             contribution. 
1997-   Navarra et al performs the first single incision laparoscopic surgery. 
1999-   Muhe presents “THE FIRST LAPAROSCOPIC CHOLECYSTECTOMY”  
             in TEXAS in STORZ conference ascertaining his place in history as the  
            first person to have performed  laparoscopic cholecystectomy . 
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LATEST ADVANCEMENTS IN CHOLECYSTECTOMY 
 
 
There was a time when the surgical society believed that “Larger problems meant larger 
incisions.” With advancements in field of anesthesia, fiber optics, instrumentation, the 
focus has shifted towards minimally invasive surgery and less or no visible scars, is the 
order of the day. 
 
Cosmesis has become an important objective. Minimal scars also mean lesser 
postoperative pain, lesser adhesions and minimal postoperative complications. This 
search has led to opening of new avenues in fields of single incision laparoscopy, natural 
orifice laparoscopic surgery, three dimensional laparoscopic surgery and robotic surgery. 
 
Stal Pert in 1687, found gall stones in a patient who underwent laparotomy for peritonitis. 
Two centuries later, Langenbuch performed the first open cholecystectomy on a patient. 
The open technique remained the gold standard procedure for nearly a century. Till the 
other methods came and took over. Open cholecystectomy is still used in cases where 
there are dense adhesions, or when a common bile duct exploration is needed in addition 
to a cholecystectomy. 
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Minilap cholecystectomy was in vogue for a short duration. Ultrasound and other 
radiographic methods were used to localize the position of the gall bladder and Calot’s 
triangle. A smaller incision, one third the size of the conventional one, is put right above 
the location of the gall bladder. The incision is deepened and with the use of retractors, 
dissection is carried out in the Calot’s triangle. In case of difficulties the incision can be 
extended as required.  
This technique is still used in places where laparoscopic techniques have not come into 
use. This technique can also be used in patients who are not fit for general anesthesia, and 
for some cases where there is a difficulty in laparoscopy and needs conversion to open 
surgery.   
 
Zolliker of Switzerland had suggested the use of carbon di oxide for creation of 
pneumoperitoneum in 1924.  
 
Veress designed a technique for creation of pneumoperitoneum using closed method. 
And Hasson introduced an open method for creation of pneumoperitoneum. These paved 
the way for the advent of modern laparoscopy. 
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Erich Muhe performed the first laparoscopic cholecystectomy in his patient when he 
found a relatively free gall bladder in a lady during gynecological laparoscopy, paving 
the way for laparoscopy in cholecystectomy. 
 
Once the news of laparoscopic cholecystectomy spread, surgeons in different parts of the 
world started attempting laparoscopic surgeries, and laparoscopic surgery overtook the 
open method and became the procedure of choice. Even after 30 years and in spite of 
many new techniques that have evolved, Laparoscopic cholecystectomy remains the gold 
standard procedure. 
 
The four port method is the conventional and still widely used method. Researchers have 
tried to reduce the number of ports and also tried using smaller ports for better cosmesis.  
 
The fourth trocar to retract the liver has been debated by many as to be an unnecessary 
addition in simple cases, and that cholecystectomy can be performed with no greater 
difficulty or increased operative time without the fourth trocar being placed. 
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The introduction of transabdominal sutures meant that the ports required to retract the 
liver lost their relevance. Sutures can be placed to on the gall bladder and anterior 
abdominal wall for retraction of the gall bladder during dissection at the Calot’s triangle 
 
This led to the two port cholecystectomy. As the number of suture placed varied from one 
to three, and it needed expertise the search for a better technique continued. This method 
also had the disadvantages that the level and retraction could not be changed during the 
surgery as per the surgeon’s need. 
 
To solve these issues SILS, or the single incision laparoscopic surgery came into the 
mainstream, it employed a special port called the R- port. The R-port is a specialized 
large umbilical trocar. It has provisions for the insertion of three 5mm instruments at 
slightly different angles at each other. This allowed for making only a single 2.5 cm 
incision in the umbilicus, created by open method, and hence left the patient with a single 
scar in the umbilicus.  
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SILS is thus an advanced minimally invasive surgical procedure. It also allows easy 
retrieval of the specimen through the large 2.5 cm incision. The only major disadvantage 
being that the R port is an extremely costly instrument and adds up to the surgical cost.  
   
The presence of a 2.5 cm scar in the umbilicus was cosmetically unsightly for a few and 
hence came the concept of Natural Orifice Transluminal Endoscopic Surgery or 
(NOTES). The use of a natural orifice for laparoscopy is being tried for a variety of 
surgery, e.g.: thyroidectomy through trans-oral route. 
 
 Cholecystectomy has now been tried through many routes and many more are in the 
process of development. Some of these techniques are trans -gastric, trans-anal, trans-
vaginal, trans-colonic routes. This requires the use of colonoscopes, vaginal platform 
instruments, staplers and flexible endoscopic instruments.  
 
The problems associated with these techniques include higher set up cost, steep learning 
curve, perforating a normal organ for access into the peritoneal cavity, chances of 
introduction of infection into the peritoneum, soiling of the surgical field and finally 
closing of the perforation created for surgery. 
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NOTES is an area that is undergoing tremendous innovations, and might throw open a 
window for development of separate branch, given its wide range of applications. 
 
Animal and human clinical experiments are being carried out in robotic surgeries. With 
the advent of robotics and robotics assisted techniques into the field of surgery, we live in 
a world where we wake up to a new and a brighter day each time.   
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LAPAROSCOPY:  
Laparoscopy is the endoscopic visualization of peritoneal cavity. It usually assisted by 
pneumoperitoneum that helps to distend the peritoneal cavity and separate the abdominal 
wall from the contents. 
This pneumoperitoneum helps in visual clarity of visualized abdominal organs. It 
provides the necessary space to perform diagnostic and therapeutic procedures. It reduces 
the chances of injury to the adjacent organs. It helps maintain normal physiological state 
which is required for safe effective surgery 
 
PNEUMOPERITONEUM:  
The gas chosen for pneumoperitoneum depends on many factors. Some of them are the 
type of anesthesia given, method of gas delivery, physiological compatibility, non-
combustibility, minimal or no toxicity of the gas, ease of use, safety, cost, no harm on 
leakage of gas, easy excretion of gas through metabolism. 
Some of the commonly employed gases are carbon di oxide, nitrous oxide, helium, 
oxygen, argon and air. Each of them have their own advantages and disadvantages and 
hence have different medical applications.  
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Creation of pneumoperitoneum:  
                    Pneumoperitoneum is created by of the two methods. Closed techniques of 
Veress and the Open technique of Hasson’s. 
                    Veress method uses a specialized needle “Veress needle” for the creation of 
pneumoperitoneum. The needle is classically 12 to 15 cm long and has a blunt end which 
is spring loaded to protect the bowel. The needle is inserted into the abdominal cavity 
after the anterior abdominal wall is lifted up to apply counter pressure and once the 
needle is inside the peritoneal cavity, the gas is insufflated and telescope port is inserted 
blindly. Other ports are created under visual guidance.  
         Advantage of Veress method being that it is quicker and needs no other 
specific instrument. Disadvantage is that, there are more chances of injury to bowel, and 
vascular structures underneath. 
 
      Open method of Hasson’s requires no such needle. And every step is done 
under vision. 1 to 1.5 cm Incision is made in the umbilicus and deepened to reach the 
rectus. Rectus and peritoneum are opened under vision and entry into peritoneal cavity is 
checked and umbilical port is inserted and gas for pneumoperitoneum is insufflated. A 
telescope is inserted under vision and laparoscopy is done. Other ports are also inserted 
under vision. 
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     Advantage of open method is that there are no or minimal risks of injury to 
bowel or vascular structures as every step is done under vision. Disadvantage is that it 
takes a longer time when compared to the Veress method. 
     The major complication of laparoscopy occurs mainly at the time of insertion of 
the umbilical trocar. These complications may result mainly due to adhesions at site of 
entry.  
 It is reported that the Veress technique is used in 62% of cases and Hasson’s 
method is used in 38 % of cases. But it is the Hasson’s method which is used by majority 
of general surgeons as it is deemed to be the safer option for access into the peritoneum.  
 The optimal pressure for pneumoperitoneum is 12-15 millimeters of mercury. 
Higher pressures may be used during the first entry port to reduce chances of injury.  
 
 
 
 
 
Carbon di oxide as the “Gas of choice” :  
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                CO2 is the most preferred gas for the creating pneumoperitoneum as it has a 
high diffusion co-efficient. It is also a normal end metabolic product; hence excess is 
easily tolerated and is rapidly cleared from the body. It offers the advantage that it is 
highly soluble in blood and tissues and carries the lowest risk of gas embolism. 
              But carbon dioxide has its disadvantages that it can cause arrhythmias, 
hypercarbia, tachycardia and acidosis in cardiac patients and in those undergoing long 
duration surgeries.  
              Carbon dioxide is easy to manufacture, easily available and cost effective. It is 
non-combustible and causes no harm to medical personnel in event of leakage. It is a 
non-irritant and has little to no smell.  
              For the above mentioned reasons Carbon di oxide is widely used and is at 
present the “GAS OF CHOICE” for creating pneumoperitoneum.  
 
 
 
 
COAGULATION PATHWAY: 
          The coagulation of blood
5 
depends on the balance between two 
groups, procoagulants and anticoagulants that is present in blood.  In response to 
endothelial damage, prothrombin activators are formed and these cause conversion of 
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prothrombin into thrombin. Thrombin catalyzes the conversion of fibrinogen into fibrin, 
which results in a stable clot. The conversion of prothrombin to thrombin requires tissue 
factor or factor III, factor X-A, factor V and calcium.              
 
 
PROTHROMBIN : 
 
Prothrombin is a plasma protein formed by the liver. It is involved in the process of 
coagulation. It is Vitamin K dependent. On exposure to prothrombin activators, it is 
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converted into thrombin. Thrombin further helps in conversion of fibrinogen into fibrin 
and thus forms clots. 
 
Prothrombin time is the indicator of concentration of prothrombin in blood. Upon 
collection, Blood is oxalated to prevent conversion of prothrombin to thrombin. large 
amounts of calcium ion and tissue factor is then mixed. This activates the extrinsic 
pathway for coagulation .The time required for coagulation is denoted as the prothrombin 
time.  
 
Normal time is around 12 seconds.  
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D-dimer: 
It is the product of degradation of crosslinked fibrin (XII Factor)
6
. It is an indicator of 
ongoing process of activation of hemostatic system. The reference value is less than 250 
ng/ml or 0.5 ug/ml fibrinogen equivalent units. 
 
D-dimer has various uses as it can be used in evaluation of thrombus formation, ruling 
out deep vein thrombosis, monitoring anticoagulant therapy, disseminated intravascular 
coagulation, and in snake venom poisoning. It is also a cost effective rapid tool to rule out 
pulmonary embolism in patients with low risk of the condition. 
 
D-dimer levels can be increased in pregnancy, inflammation, malignancy, heart diseases, 
trauma, liver diseases and post-surgical treatment. 
 
In an adult with a clinically low pretest probability (Well’s score), there is a 99 % 
negative predictive value, when the d-dimer test is negative, in patients less than 80 years 
of age. 
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REVIEW OF LITREATURE 
 
       Sages { Society of American Gastro and Endoscopic Surgeons } 7 
recommendation:  
 
                  “Prophylaxis has to be tailored for each patient based on their estimated risk. 
All laparoscopic procedures carry a risk of hypercoagulability. Short and less 
complicated or less complex procedures like laparoscopic appendectomy and 
laparoscopic cholecystectomy carry a low risk of venous thromboembolism.”  
                    “Patient positioning during surgery may alter the DVT risk. But the evidence 
is not significant enough to suggest that DVT prophylaxis should be changed based only 
on body position. The reverse trendenlenberg position and increased intraabdominal 
pressure may decrease the venous return and thus cause increased risk for deep vein 
thrombosis.” 
 
  “Laparoscopic procedures that extend beyond one hour may need venous 
thromboembolism prophylaxis. Compression dressing, unfractionated heparin, low 
molecular weight heparin may be used to this effect.” 
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                    SAGES recommends that the risk factors for deep vein thrombosis are 
duration of surgery greater than 1 hour, previous H/o venous thromboembolism, age 
more than 40, myocardial infarction in the past, features of  congestive cardiac failure, 
immobilization, patients undergoing  hormone replacement therapy, varicose veins, oral 
contraceptive use, diagnosed malignancy,  multiparous women, history of  chronic renal 
failure, known case of  inflammatory bowel disease, severe infection and obesity   
 
                  SAGES recommends that each of the factors are given one point. If the total 
of positive factors is 0 or 1 then the patient need not be given prophylaxis or the patient 
may be subjected to one method, either pneumatic compression dressings or 
Unfractionated Heparin(UH) or low molecular weight heparin(LMWH). 
 
                 If the sum of the factors is 2 or greater than 2 then the patient has to be put on 
unfractionated heparin or low molecular heparin in addition to pneumatic compression 
dressing to prevent deep vein thrombosis. 
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            The University of Michigan gives a table 
8
 and its own recommendations for deep 
vein prophylaxis. These recommendations are widely accepted across multiple specialties 
and also by anesthetists worldwide. 
                The table consists of a list of factors- high risk ones carrying 5 points medium 
risk factors carrying 3 and 2 points and a low risk factors carrying 1 point each. The sum 
of positive factors is derived and recommendations are given for each category. 
 
Scores of zero carry a very low risk and need no further action. 
Patients having score of 1 and 2 have a low risk and may need compression dressings. 
Patients with scores of    3 and 4 have a moderate risk and need compression dressing or 
heparin. 
Patients with scores of 5 and above carry a high risk of DVT and need both heparin and 
compression devices. 
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2 points 3 points 
61-74 years of age Age greater than 75 years 
Central venous access Family H/o thrombosis 
Laparoscopic surgery duration(>45min) H/o  DVT / PE 
Arthroscopic surgery Positive Prothrombin 20210A 
Major surgery (duration >45 minutes) Positive Factor V Leiden 
Malignancy  Positive Lupus anticoagulant 
Immobilizing plaster cast <1 month Heparin-induced thrombocytopenia (HIT) 
Patient confined to bed >3 days Elevated anticardiolipin antibodies 
Factors carrying    5 points 
Stroke within last 1 month 
Multiple trauma  within the past 1 month 
Acute spinal cord injury within 1 month 
Elective major lower extremity arthroplasty/Hip, pelvis or leg fracture  
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FACTORS CARRYING     1 POINT 
Age between  41-60 years  
Myocardial infarction 
History of major surgery within the past 1 month 
Minor surgery planned 
H/o inflammatory bowel disease 
Obesity (BMI greater than 25) 
Patient currently at bed rest 
Varicose veins 
Congestive heart failure  
Swollen legs : edema –thrombophlebitis 
History of Sepsis in the past 1 month  
Abnormal pulmonary function 
Oral contraceptives treatment  or hormone replacement therapy 
History of unexplained stillborn infant in the past 
Pregnancy or postpartum  in the past 1 month 
More than 3 Recurrent spontaneous abortion  
Premature birth 
Serious respiratory disease including pneumonia 
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Deep vein thrombosis prophylaxis can be given by one of the following methods.  
 
Pneumatic compression devices are calf length pneumatic devices which increase lower 
extremity venous blood flow they also cause fibrinolysis. The advantage of pneumatic 
compression device is that they don’t pose an increased risk of bleeding. Disadvantage is 
that once features of deep vein thrombosis set in the use of these devices may carry an 
increased risk. 
 
Unfractionated heparin is given subcutaneously or through intravenous route. It is given 
in the dosage of 5000 international units 6
th
 hourly. The disadvantage of unfractionated 
heparin is that it has to be repeated multiple times a day. It also has an increased risk of 
bleeding. It can be stopped 6 hours before surgery and started six hours after surgery 
Low molecular weight heparin is usually given in a twice daily dosing. It is administered 
through subcutaneous route. This delivers a lower dose and has lesser incidence of 
heparin induced thrombocytopenia.  
A combination of the above is frequently used for Deep vein thrombosis prophylaxis. 
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STUDIES AND THEIR RESULTS 
                 
                          Alteration in the hemodynamics during laparoscopy depends on 
concomitant disease process, intraabdominal pressure during surgery, amount of carbon 
di oxide that gets absorbed during circulation, position of the patient during surgery, 
nature of the procedure, operative time and neuro-humeral response. The intravascular 
volume, preexisting cardiac status and anesthetic agent used also play a role. 
                 The following studies look into the relation between  Carbon dioxide 
pneumoperitoneum –reverse trendenlenberg position on the cardiovascular and 
coagulation system.  
                        Baker .J et al 
9conducted a study on 60 patients and found that “Carbon di 
oxide pneumoperitoneum may cause blunting of inflammatory response due to acidosis at 
cellular level” 
                        Kehlet 
10
 also mentioned that “There is not much difference in the 
coagulation system in laparoscopic and open procedure and changes could mainly be 
attributed to the position of patient in laparoscopic surgery (Reverse Trendenlenberg).” 
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                Kehlet et al.
 10
  stated that “Carbon di oxide pneumoperitoneum may 
attribute to increased post-operative morbidity. Patients undergoing laparoscopic 
surgery with carbon di oxide had higher incidence of nausea, vomiting, shoulder pain 
and fatigue when compared to those undergoing gasless cholecystectomy.” 
 
                     Kehlet et al 
10
 stated “There is no major difference on endocrine and 
metabolic response between the groups undergoing laparoscopic and open procedure but 
there is a marked decrease in inflammatory response in the former.” 
 
                 Marshal et al
11 stated “Cardiac output ,central venous pressure, heart rate and 
mean arterial pressure (MAP) measurements remained the same before and after carbon 
di oxide insufflation during laparoscopic procedures.” 
 
                          But they also mentioned that “There was an increase in the partial 
pressure of carbon di oxide and decrease in the pH during creation of 
pneumoperitoneum.”  
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                  In a study in 60 patients Chopra et al 
12
 found that “There was a highly 
significant increase in heart rate, end tidal carbon di oxide, systolic blood pressure, 
diastolic blood pressure and mean arterial pressure in the laparoscopic group. There were 
also changes in the SpO2, electrocardiogram of patients in the laparoscopic group.” 
                  Chopra et al mentioned that “These physiological changes need no major 
intervention at most times but they need continuous monitoring peroperatively and post 
operatively to pick complications if any arise.”         
 
                 Muller C M et al 
13
 conducted a study on 119 patients and told that “Carbon di 
oxide output increases upto 50 % in patients undergoing laparoscopic cholecystectomy.” 
 
                 Cunningham et al 
14
 in a study of 103 patients found that “Patients put in 
reverse trendenlenberg position had a 50% decline in cardiac index and a 50% fall in 
venous return.”  He also noted an increase in heart rate and mean arterial pressure.  
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Laparoscopic cholecystectomy was reported to have no effects on the coagulation 
system in various studies. 
           Dexter et al 
15
 studied 26 patients and he analyzed clotting factors. “Stress 
response, cytokine release and neuro-humeral response during surgery were stated as the 
major factors that caused thromboembolic phenomenon. Of the 26 patients studied, only 
Euglobin clot lysis time was found to be raised. All other clotting factors were found to 
be normal. He hence concluded that laparoscopic surgery does not increase the risk of 
thromboembolism.” 
 
             Jens Fromholt 
16
 compared laparoscopic surgeries done using carbon di oxide 
with ones conducted without pneumoperitoneum and stated that “There was no difference 
in the prothrombin time and d-dimer in both the groups.” 
 
                 He hence concluded that “He could not decide if patients undergoing 
laparoscopic cholecystectomy were at a higher risk of thromboembolic complications 
when compared to patients undergoing gasless cholecystectomy” 
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                       Dabrowiecki et al 
17
 conducted a larger study on 100 patients. He took 
blood samples from upper limb (cubital vein ) and lower limb (femoral vein)  post 
operatively in patients undergoing laparoscopic procedures and revealed that “There was 
no change in the coagulation profile of the two samples and suggested that the venous 
stasis in lower limbs in  these patients does not contribute to alterations in the hemostatic 
mechanisms.” 
                       
                      Khairy et al
18
 found that “The change in the thrombin time was not 
significant post-surgery. He indicated that the pneumoperitoneum thus did not alter the 
thrombin time in the patients and postoperative thrombosis did not correlate to the 
thrombin time.”  
                      Martinez Ramos et al
19
 observed twenty patients on a long term basis. He 
took multiple samples: preoperatively, at the onset of pneumoperitoneum, at the end of 
surgery, 24 hours after surgery and 7
th
 day post operatively. He saw there were no 
thromboembolic phenomena even after 16 months of follow up. 
 
              Rahr et al
20
 found that “The coagulation profile did not change much and hence 
no major changes occurred in the coagulation system in patients who underwent 
laparoscopic procedures.” 
 35 
 
              Joegruson T et al
21
 studied the Partial thromboplastin time, Anti X-A, fibrinogen 
in patient undergoing laparoscopic cholecystectomy. Samples were taken 1 hour before 
surgery, 24 hours after surgery and 7
th
 Post-operative day. He concluded that there were 
no significant changes in the values studied. 
 
            Natkaniec et al
22
 postulated that laparoscopic surgery caused stasis of blood in the 
inferior vena cava and common iliac vein. He studied coagulation profile in 25 patients 
and told that there was no change in the coagulation profile of patients.  
 
Multiple studies have been conducted to assess the risk of thrombosis post 
laparoscopic cholecystectomy. The following studies inferred that the risk of 
thromboembolism increased post surgery. 
                      
                  Trifeletti et al 
23
 noted that “In circumstances such as traumatic injuries and 
surgery in patients, the level of fibrin A peptide was elevated and a consequent increase 
in the level of blood fibrinogen occurred. This led to hyper coagulation.” 
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                 Trifilleti et al 
23
 noticed that “There was a significant increase in the fibrinogen 
levels 8 hours after surgery. This, he noted, may be due to the decreased response against 
stress. This decreased response to stress may be due to pneumoperitoneum, anesthetic 
that act on liver, decreased blood flow through the portal vein, fluids infused during 
surgery.” 
                       
                   He concluded that “The concentration of fibrinogen is the highest eight hours 
post-surgery. And this time period poses the greatest risk for further development of 
DVT.” 
                           
              Huang et al
24
 discovered that “The postoperative alterations in the coagulation 
system is one of the main causes of deep vein thrombosis.” 
 
              Hans et al
25
 reported that “Activation of the coagulation system by laparoscopic 
procedure causes promotion of hypercoagulable state.” 
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                     Garg et al 
26
 reported that “Carbon dioxide pneumoperitoneum enhanced 
coagulation system and fibrinolytic system activation and hence a state of 
hypercoagulation occurred in these patients.”  
           
                     Amin et al
27
 studied the coagulation profile of patients undergoing 
laparoscopic cholecystectomy. He inferred that “While the prothrombin time was 
elevated the activated partial thromboplastin time remained the same. This they said may 
lead to hypercoagulable states even within 6 hours post-surgery.” 
 
On the contrary some studies found that hypocoagulable states were common after 
laparoscopic surgery 
              
               Schietroma et al
28 
 studied the cytokine levels in patients undergoing 
laparoscopic and open procedure and found that “ Hypercoagulation was seen almost 
after every surgery. This was attributed by him to the increased cytokine level. Since 
laparoscopic surgery causes lesser tissue damage, it releases lesser cytokines hence 
causes lesser hypercoagulability when compared to open surgery.”  
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            Schietroma et al further stated that “Prothrombin fragment, fibrinogen, 
plasminogen, D-dimer, soluble fibrin and Protein C, all were raised in open surgery 
compared to laparoscopy”. He concluded that only mild hypercoagulability resulted after 
laparoscopic cholecystectomy and further studies are required to confirm the findings. 
 
                 Lauro et al
29
 observed 36 patients. He divided them into two groups 
laparoscopic and open, half of each group was put on deep venous thrombosis 
prophylaxis and other half was not given prophylaxis. He said that laparoscopy is 
associated with increased resistance to venous return from both the lower limbs and the 
resultant stasis could promote thromboembolic phenomenon. 
                  
                 He observed that fibrinogen and D-dimer were significantly higher in the open 
group   while prothrombin time and partial thromboplastin time were unaffected. 
Perioperatively coagulative fibrinolytic changes were lower in laparoscopy when they 
were compared to the counterparts in the opposite group. And hence concluded that 
laparoscopy may indeed be advantageous with respect to coagulation system.  
                  Yan MJ et al
30
 found in his studies that “The levels of fibrinogen decreased 
after surgery. Thus patients are in a hypocoagulable state.” 
 
 39 
 
The timing of highest risk for thrombosis were reported at various time intervals 
following laparoscopic cholecystectomy 
 
            Custendil et al
31
 reported “Higher incidence of thrombosis on the first post 
operative day following surgery.” 
 
              Lord RV et al
32
 reported “Higher incidence of thrombosis on the third post 
operative day following pneumoperitoneum.” 
  
            Amin Buhe et al
33
 suggested that “The first 8 hours following surgery carry the 
highest risk of thrombosis, this is because the patient is immobilized in bed , is in a state 
of fasting, discontinued on anticoagulation therapy, patient was on pneumoperitoneum.” 
                  He postulated that “The patients are at high risk within 8 hours after surgery 
for development of thrombosis, and 8 hours post-operation is the pivotal period of venous 
thrombosis”. 
 
The incidence of thrombosis too varied from 0.02% to as high as 55% depending on 
the technique used for diagnosing thrombosis 
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               Milic DJ et al
34
 in their study on 100 patients have stated that “Only one patient, 
a 73 year old female had evidence of deep vein thrombosis post operatively, and even this 
patient was observed and conservatively managed.”  
     
Millikan et al
35
 did a  metaanalysis  of close to 77000 cases in 4000 hospitals , and 
reported just 3 fatalities due to deep vein thrombosis after surgery for laparoscopic 
cholecystectomy. 
 
            Patel et al
36
 in a study of 20 patients reported that 11 patients developed signs of 
venous thrombosis radiographically, with none of the eleven being suspected clinically. 
The incidence of thrombosis was as high as 55%. 
 
           Milic et al
37
 found an incidence of 6.9% and 16.07% in the laparoscopic group (4 
out of 58) and open group (9 out of 56) . None of the 114 patients were given deep vein 
thrombosis prophylaxis. 
 
                 Lindberg et al
38
 reported a frequency of 2% in a study done on 50 patients after 
laparascopy. All the patients had been on prophylaxis and diagnosis was done using 
bilateral phlebography in the second week following surgery. 
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               Blake et al
39
 in a study conducted over 4 years on 587 patients , found signs of 
Deep vein thrombosis in none of the patients over a four week follow up. Eighteen 
patients in the study were on some form of prophylaxis.  
              He thus questioned the purpose of routine DVT prophylaxis in these patients as 
the was no risk benefit ratio and it added up to the medical costs incurred by the patient 
 
           Wazz et al
40
 reported “In a study of 61 patients, none of them on prophylaxis, no 
incidence of postoperative thrombi on duplex scanning after unspecified laparoscopic 
procedures.” 
 
                   Mohammed Ali et al
41
 stated that in over 100 cases of laparoscopic 
cholecystectomies followed up with duplex scan, physical examination ,only one case of 
partial thrombosis was seen (by duplex). None were on DVT prophylaxis. He hence 
conferred laparoscopic cholecystectomy a low risk procedure. 
 
                 Schaepkens et al
42
 reported 5 cases in whom DVT manifestations were picked 
up in duplex scan ,four in the group not receiving prophylaxis and one in the group 
receiving prophylaxis , in a study of 238 cases . He put the incidence at 2.10%. with no 
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significant difference in incidence between the groups receiving and not receiving 
prophylaxis. 
     
                   Lindberg et al
43
 reviewed 60 case series of laparoscopic cholecystectomy, 
with a total of 1,53,832 patients. He gave an incidence of 0.02% for fatal pulmonary 
embolism and 0.03% for deep vein thrombosis. He concluded that laparoscopic 
procedure was much safer than conventional procedure with respect to thromboembolic 
phenomenon. 
 
                 Alatri et al
44
 reported two cases of deep vein thrombosis, one in a case of 
laparoscopic hernia repair and another in a case of laparoscopic cholecystectomy. And 
reported that venous thromboembolism prophylaxis be given in patients even if the 
procedure is relatively noninvasive and laparoscopic. 
 
 
 
               Mayol et al
45
 have reported “Two cases of pulmonary embolism after 
laparoscopic cholecystectomy and suggest a specific prophylaxis for prevention, as the 
risk of pulmonary embolism must not be underestimated.” 
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           Stein et al
46
 put the incidence of Pulmonary embolism at 0.15%, Deep vein 
thrombosis at 0.40%, and Venous thromboembolism at 0.53%. This was after a review of 
patients who underwent laparoscopic cholecystectomy between 1998 till 2009. 
              He reports the fatalities to be 780 cases (0.02%) of the total 4,107,430 
cholecystectomies. Fatalities increased with age. 
 
             Morris DL et al
47
 have reported in a study of over 438 patients three cases had 
thromboembolic manifestations, one deep vein thrombosis, one fatal pulmonary 
embolism and a non-fatal pulmonary embolism.   
 
             He stated that post surgery there was increased fibrinolytic changes in plasma 
and this caused hypocoagulability of blood post-surgery and thus laparoscopic surgery 
decreased the risk of thromboembolism in these patients. 
 
Studies were done to assess the risk benefit ratio of uncontrollable bleeding in 
patients receiving thromboprophylaxis  
               Persson et al
48
 studied the incidence of uncontrollable peroperative bleeding in 
patients undergoing laparoscopic cholecystectomy who were put on prophylaxis. There 
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were 400 patients who had uncontrollable peroperative bleeding and 296 patients with 
postoperative bleeding. The odds ratio was 1.35 when compared to those who did not 
receive prophylaxis. 
             
               He mentioned that while the incidence of uncontrollable bleeding after 
prophylaxis increased, the incidence of thromboembolic phenomenon did not decrease in 
the patients receiving prophylaxis.   
 
               In a study conducted by Bradbury et al
49
, he distributed questionnaires to 800 
surgeons who performed laparoscopic cholecystectomy, 417 responded. He found that 
74% recommended prophylaxis to all their patients and 20 % prescribed prophylaxis 
selectively. Surgeons performing lesser than 10 procedure per annum were more 
concerned about bleeding manifestations and hence used prophylaxis selectively. 
 
              Filtenborg et al
50
 used the questionnaire method to assess the use of 
thomboprophylaxis by Danish surgeons performing laparoscopic cholecystectomy. He 
found that 93% of the institutions had a written protocol. 
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              He observed that 37% surgeons used prophylaxis for all their patients and 7% 
used it selectively on their patients. 74 % used compression devices to counter this 
problem and 20% of surgeons reported to have faced thromboembolic complications 
following laparoscopic surgery. 
 
              Haas S et al
51
 concluded after his study that “Shorter and less complicated 
laparoscopic procedures don’t need Deep vein thrombosis prophylaxis.”  
 
               Lord RV et al
52
 divided 100 patients into two groups, half underwent minilap 
cholecystectomy and other half underwent Lap cholecystectomy. Both groups were put 
on prophylaxis for deep vein thrombosis prophylaxis, he mentioned that “if prophylaxis 
was given for DVT, there was no risk for thromboembolic phenomenon in both group of 
patients undergoing cholecystectomy.” 
 
               Amin Buhe et al
53
 studied the effects of laparoscopic cholecystectomy on 
coagulation profile he inferred that “Pneumoperitoneum for laparoscopic 
cholecystectomy may cause post-operative hypercoagulation. In patients and  
hence may face increased risk for development of thrombosis and embolism 
postoperatively.” 
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                He further stated that “Patients may have the increase in risk even within 8 
hours after the operation, which requires specific attention to prevent thrombosis. 
Thrombotic disorders being a severe complication, if not found and managed at the right 
time may progress into pulmonary thrombosis threatening the patients’ lives.” 
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MATERIALS AND METHODS: 
 
This study will be a CLINICAL OBSERVATIONAL of 50 patients done at General 
Surgical department of Kilpauk Govt. Medical College Hospital between January 2015 to 
September 2015. 
 
 SIZE OF THE STUDY:   
          50 patients undergoing laparoscopic cholecystectomy. 
 
STUDY METHODOLOGY 
           Patients who get admitted to Department of General Surgery, Government Kilpauk 
medical college hospital and who were diagnosed to have a gall bladder pathology and 
underwent laparoscopic cholecystectomy were included in the study.  All who satisfied 
the inclusion criteria were retained in the study group and those who did not were 
excluded from the study. Consent was obtained from the patient regarding inclusion in 
study. History and clinical examination was done. Patient`s age sex, symptoms and their 
duration of surgery were recorded.  
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METHOD OF COLLECTION OF DATA: 
  50 eligible patients are chosen. 
 Clinical assessment done at time of inclusion in the study. 
 Detailed history and examination done. 
 Basic routine investigations will be done for all patients 
 3 cc of blood will be drawn under strict aseptic precautions  
 One sample prior to surgery  
 One sample 6 hours after onset of pneumoperitoneum 
 Samples will be processed for prothrombin time and D-dimer 
 Duplex scan will be done to look for deep vein thrombosis 
 Consent will be obtained for inclusion under study and for surgery 
 
METHOD OF SURGERY :  
 Procedure will be done under general anesthesia. 
 Surgery will be done with standard laparoscopic  equipment for all patients using 
carbon di oxide pneumoperitoneum  
 The pressure of pneumoperitoneum will be  maintained at 13 mmHg +/- 1 mmHg 
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SURGICAL STEPS:  
 Patients will be put in classical supine position with table given a 30 degrees 
head up position and 15 degrees right up position to allow better visualization 
of gall bladder and Calot’s triangle as it allows the colon and duodenum to fall 
away from the liver edge. 
 Surgeon stands on the left of the patient with monitor placed near the right 
shoulder. 
 A nasogastric tube and Foleys catheter are inserted to deflate the distended 
stomach and empty the urinary bladder. 
 Pneumoperitoneum is created by open Hasson’s method. A 1 to 1.5 cm 
incision is made in the umbilicus. Dissection is carried out and rectus sheath 
and peritoneum are opened in layers. 
 After confirming entry into the peritoneal cavity, a 10 mm port is inserted and 
carbon dioxide is insufflated to a pressure between 12-14 mm Hg at a flow rate 
of around 3 to 3.5 liters per minute. 
 A 0 degree 10 mm telescope is attached to light source and endo camera and 
inserted through the 10 mm port. 
 Laparotomy is done to exclude injury to structures during port insertion, to 
exclude other suspected or associated pathologies and assess the feasibility of 
laparoscopic procedure. 
 50 
 
 Rest of the ports are inserted under vision. A 10 mm working port is created in 
the epigastrium to the right of falciform ligament. Two 5mm port one each in 
the midclavicular line and another in the anterior axillary line are created to 
retract the gallbladder and to visualize the Calot’s triangle. 
 The cystic pedicle is exposed and dissection is carried out to create a window 
all around the cystic duct. Three clips are applied and cystic duct cut in 
between. Cystic artery is then isolated and clips applied and cut. 
 The gall bladder is then removed from the liver bed by dissection in the loose 
fibrous layer which separates the gallbladder from the fascia covering the bed 
of the liver. 
 The gall bladder is then delivered through the epigastric or the umbilical port. 
 Hemostasis is ascertained and ports are removed under vision and 
pneumoperitoneum is released. 
 Wound is closed in layers and patients are given analgesics for pain relief. 
 Specimen is sent for histopathological examination and stones if present are 
sent for biochemical analysis   
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INCLUSION CRITERIA  
 
• All patients operated for cholecystectomy laparoscopically will be included 
in the study. 
• Patient of both sexes. 
• Age from 18 years to 60 years. 
• Patients with gall stones or gallbladder polyps. 
• Patients with chronic cholecystitis, relief stages of acute cholecystitis will 
be included. 
• Surgery time between 90- 180 minutes. 
• Patients who give consent for study will be included. 
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EXCLUSION CRITERIA  
• Patients below age of 18 and above the age of 60. 
• Surgery time exceeding three hours. 
• Procedures converted to open surgery. 
• Associated hypertension. 
• Patients on anticoagulant therapy. 
• Patients with known malignancies.  
• Patients with known history of bleeding and clotting disorders. 
•  Deep venous thrombosis. 
•  Pregnancy. 
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Reasons for inclusion / exclusion: 
 
 Age <18 left out because of problems with consent. 
 Age >60 excluded because of abnormal coagulation profile in elderly. 
 Patients with acute cholecystitis excluded because acute inflammation alters  
coagulation profile. 
 Associated hypertension, malignancies, use of oral contraceptives excluded since these 
alter coagulation mechanisms. 
 Surgery time greater than 3 hours excluded as they are known to 
produce thrombosis. 
 Associated deep vein thrombosis and patients with bleeding 
disorders have an altered profile; hence are excluded. 
 Pregnancy is excluded because of altered profile and ethical 
issues.  
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INVESTIGATIONS: 
• Complete hemogram  
• Urine routine 
• Blood sugar 
• Blood urea 
• Serum creatinine  
• Serum electrolytes  
• USG abdomen 
 
SPECIFIC INVESTIGATION 
 Coagulation profile : Prothrombin Time  
                                        D - dimer 
 Duplex scan if indicated . 
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PROFORMA 
1. Patient name  
2. IP No:  
3. Department:  
4. Hospital: 
5. Age: 
6. Sex: 
7. Occupation 
8. Chief complaints: 
9. Past history: 
     10. Body mass index: 
11 General examination. 
    12.  Vitals  
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           a. Pulse rate:    
b. Blood pressure:    
c. Temperature: 
     
13.Local examination: 
 a. Inspection  
           b. Palpation: 
c. Percussion: 
          d. Auscultation: 
  14.Abdominal examination 
   
  15.Cardiovascular and respiratory system examination  
  16.Diagnosis:  
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Duration of surgery :  
Table : 
 Before surgery 6 hours after surgery 
Prothrombin time   
D-dimer    
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Data analysis : 
 
Data collection was done. The prothrombin time and D-dimer values before and after the 
surgery were collected for all the 50 patients and were entered into the Microsoft excel 
sheet. The values were used for analysis. 
 
The Paired student T –test was used to analyze the values collected before and after the 
surgery . The software tools used for the purpose were downloaded from the internet . 
The values obtained were confirmed using another similar software to check the validity. 
 
 The mean of the two groups , the standard deviation, standard error of mean and the P-
value were calculated. The results were again converted into pie charts, bar diagrams and 
scatter map for the sake of easy understanding , and are presented as follows. 
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D DIMER 
 BEFORE SURGERY AFTER SURGERY 
MEAN 129.78 350.22 
STANDARD DEVIATION 21.01 73,21 
STANDARD ERROR OF 
MEAN 
2.97 10.35 
 
 
 
 
  
PROTHROMBIN TIME 
 BEFORE SURGERY AFTER SURGERY 
MEAN 11.83 11.7 
STANDARD DEVIATION 1.008 0.898 
STANDARD ERROR OF 
MEAN 
0.143 0.127 
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Results:  
                       Of the 50 patients operated , 31 were female and 19 were male patients. 
The most common age group was 41-50 years among both female and male groups. 
Followed by the age group of 51-60. 
                      The duration of the surgery ranged from 1hour 25 minutes to 2 hours 50 
minutes. The reasons for prolonged surgical time were dense adhesions in the Calot’s 
triangle and gall bladder adherent to the liver bed. 
                     There were no major peroperative complications. There was wound 
infection at the umbilical site in 3 patients which settled with conservative treatment with 
a course of antibiotics. 
                    There were no major postoperative complications in the operated patients 
during hospital stay and during the follow up period. The mean hospital stay was 4 days. 
                    The prothrombin time of the patients before surgery ranged from 10 to 13.5 
seconds, with the mean at 11.83 seconds. The standard deviation was 1.008 and standard 
error of mean was 0.143. 
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                      The prothrombin time of patients 6 hours after surgery ranged from 10.5 
seconds to 14 seconds . The mean of prothrombin time after surgery was 11.7 seconds. 
The standard deviation was 0.898 and the standard error of mean being 0.127. 
                      Not all patients had a change in prothrombin time before and after surgery. 
While some had elevated prothrombin time, some had decreased prothrombin time and 
few showed no change at all. 
  The difference in the mean between the two groups was 0.130. The  
confidence interval at 95% was between 0.031 to 0.229. The p- value was 0.0109   
(<0.05) . Hence the value was statistically extremely significant. 
 
                  The values for D-dimer were analyzed . The D-dimer value before surgery 
for the 50 patients ranged from 99 to 178 , with the mean at 129.78. The standard 
deviation was 21.01 and standard error of mean was at 2.97. 
  The D-dimer values after surgery varied between 199 and 506. The mean 
was calculated to be 350.22 with the standard deviation at 73.21 and standard error of 
mean at 10.35.  
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                   The D-dimer of all the patients showed a drastic increase post surgery. The 
difference in mean of the two groups was 220.44 and the confidence interval of 95 % lay 
between 240 to 200.83. The p-value of the D-dimer analysis was at 0.001was meant it 
was extremely significant  statistically. 
 
                        On follow up none of the patients developed signs of deep vein thrombosis 
clinically when they turned up for follow up to 2 weeks post surgery.  
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Discussion: 
 
The values of prothrombin time and D-dimer of the 50 patients were analyzed. The  
inferences derived from them were compared with other similar studies.  
 
There was a higher incidence of female patients undergoing cholecystectomy 62%, 
compared to male 32%. This matches the global rates and rates in India which also shows 
a higher female predisposition towards gall bladder pathologies. 
 
The majority of the patients who underwent surgery were in the age group of 41-50 years 
in both the sexes. The second highest was seen in the age group of 51-60 years. These 
two groups constituted 76% of the cases. Showing that the disease incidence increased 
after the age of 40 years.  
 
The duration of surgery varied between 1 hour 25 minutes to 2 hours 50 minutes. This 
shows the unpredictability of the duration of the surgery the longest taking twice the time 
for the shortest procedure.  
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The prothrombin times of patients when analyzed showed that the results were not 
uniform for all patients . while some showed an elevation in prothrombin time indicating 
hypocoagulability , there were a few who had decreased prothrombin time after surgery 
showing hypercoagulability.  
 
The prothrombin time was not altered in most of the patients 62% (31 out of 50). This 
gave the appearance that there was not much difference in the coagulation profile with 
respect to prothrombin time.  
 
The mean of the prothrombin time before surgery was 11.83 and the one after surgery 
was 11.7.  The standard error of mean was 0.143 and 0.127. This small value showed the 
accuracy  of the mean and that a similar mean would have been obtained with a study 
with a larger sample. 
 
These values when charted showed that the decrease in the mean was statistically 
significant. Hence the prothrombin time can be considered to decrease , and there is 
hypercoagulability of blood. 
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The study goes in line with other studies by Hans et al 
25
, Garg et al
26
 and  Schietroma et 
al
28
 who also support the fact that there is a state of hypercoagulabilty. 
 
When the D-dimer values are analyzed, all the patients are seen to have an increase in the 
d-dimer values. With many showing a two fold increase in the d-dimer values before and 
after surgery. 
 
The mean of the D-dimer before and after surgery where calculated to be 129.78 and 
350.22 and the standard error of mean was 2.97 and 10.35. The difference in the mean 
was 220.44 .This increase clearly indicates the undergoing fibrinolytic process.  
 
Statistically too the values were found to be extremely significant with a p value of 0.001. 
thus this increase in d-dimer suggests the high risk of thrombosis leading to activation of 
fibrinolytic systems.  
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The high values of D- dimer post surgery were also seen in many studies like the study 
by Amin buhe
33
  et al where post operative d-dimer values have been shown to get 
elevated by close to 5 times the pre operative values. 
 
The findings of the study though contradicts the studies by Rahr et al 
20
 ,Yan MJ
30
 et al , 
Martinez et al
19
. who report hypocoagulabilty of blood post operatively or no change in 
coagulation profile. 
 
The change in the coagulation profile can be attributed to be due to surgery and is not 
specific to laparoscopy with carbon di oxide pneumoperitoneum as other studies by Jens 
Fromholt 
16
and Schietroma et al
28
 have shown similar rise in values after open surgery 
and gasless laparoscopic surgeries too. 
 
D-dimer is not specific for pulmonary thrombosis or deep vein thrombosis. The changes 
or increase can be brought out by surgery in itself. The quantum of change brought by 
surgery has not been studied though. Values greater than 250 ng/ml are indicative of 
fibrinolytic activity. 
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 These changes in coagulation factors cannot be attributed to the position of patient alone. 
All the patients being put on reverse trendenlenberg position with a 30 degree tilt with a 
right up tilt given. Not all patients showed a similar change in coagulation profile.  
 
The effect of position can only be studies if studies are done comparing laparoscopic 
procedures that adopt a trendenlenberg position to procedures that employ reverse 
trendenlenberg position.  
 
The effect of increased abdominal pressure may have a role to play in the alteration of 
coagulation profile. Increase in intraabdominal pressure is associated with decreased 
venous return, venous pooling in lower limbs and pelvis and this stasis in the lower half 
of the body could contribute significantly to the observed changes. 
 
Stasis of blood is a component of Virchow’s triad5 and could trigger the coagulation 
pathway. Intra abdominal pressures of 12-14 mmHg are maintained for a period of few 
hours during laparoscopic surgery.  In patients suffering from chronic liver disease with 
ascites , abdominal pressures ranging from 15 mmHg to as high as 80 mmHg have been 
recorded
6
. These pressure are present for periods ranging from weeks to months. But 
these patients are not at increased risk for thrombotic phenomenon. This can also be due 
to decreased production of coagulation factors by the diseased liver and steady increase 
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in pressure allowing time for homeostatic mechanism. Hence increased intraabdominal 
pressure cannot be held solely responsible for the alteration in profile of coagulation. 
 
While Custendil et al
31
 and Lord RV
32,52
 in their studies found increased incidence of 
thrombosis on the first and third days following surgery , no such observations were 
made during the study.  
 
None of the patients in the study were put on prophylaxis of any form because there were 
no added risk factors that indicated their need. .  
                      On the contrary to many studies that reported the incidence of thrombosis 
postoperatively, there were no cases who developed signs of thrombosis though the 
patients showed increased coagulation profile. This was probably due to the small size of 
the population under study. The incidence of post operative thrombosis was placed at 
0.02 % (1 in 5,000) in the larger studies done elsewhere.  
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                    The analysis of these factors, show that causation of deep vein thrombosis is 
multifactorial, and only carbon di oxide pneumoperitoneum cannot be held responsible in 
patients undergoing laparoscopic cholecystectomy. But Laparoscopic cholecystectomy 
using carbon di oxide pneumoperitoneum does play a role in altering the coagulation 
profile of patients, and hence may need the use of prophylactic measures for thrombosis 
in high risk individuals.   
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Conclusion :  
             The study was done with the objective to find if there was a change in the 
coagulation profile in laparoscopic cholecystectomy using carbon dioxide 
pneumoperitoneum and if there is an increased risk of thrombosis. 
                      The study shows a marked increase in the d-dimer values and a significant 
decrease in the prothrombin time. This goes to prove that there is activation of both 
coagulation and fibrinolytic systems post laparoscopic cholecystectomy.  
                     This activation of coagulation system could spell a disaster if the patients 
were to face a thromboembolic phenomenon post cholecystectomy. But none of the 50 
patients operated by us had any thromboembolic problems postoperatively. This could 
mean that the body has effective counter mechanisms to deal with this change in 
coagulation profile. 
                      
               When assessed if there is a need for prophylaxis against thrombosis, the study 
shows change in the coagulation profile resulting in a hypercoagulable state. 
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           Hence it is better that for patients undergoing laparoscopic cholecystectomy 
stringent measures are taken and patients are put on some form of  stringent deep vein 
thrombosis prophylaxis, preferably Low molecular weight Heparin.  
 
           The surgeon is hence left with a daunting task of looking into the cost- risk- 
benefit ratio for individual patients with respect to deep vein thrombosis prophylaxis. The 
presence of even a single risk factor should necessitate the surgeon to start the patient on 
prophylaxis to avoid dire consequences. 
 
           Finally larger and detailed studies are required to throw more light on these 
changes in the coagulation system and quantitatively determine the risk associated for 
laparoscopic cholecystectomy using carbon di oxide pneumoperitoneum.  
 
  
 83 
 
Limitations: 
 
1) The study was conducted on a small size of 50 patients. A study with a 
larger sample size could have yielded different results. 
 
2)  The study was conducted only for patients undergoing cholecystectomies 
laparoscopically. 
 
3) Patients treated for other diseases using carbon dioxide pneumoperitoneum 
laparoscopically could have changes in their coagulation profile 
 
4) In the study blood sample was taken 6 hours after the onset of 
pneumoperitoneum. Samples taken at a different time period could have  
produced  different results. 
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S.NO 
IP 
number Age Sex PT BS PT AS D-dimer BS D-dimer AS 
1 149146 45 M 12 12 104 332 
2 245 41 M 13 12.5 99 241 
3 641 39 F 13.5 14 113 356 
4 1025 49 F 11 11 105 199 
5 975 58 F 13.5 13.5 156 302 
6 1189 57 M 10.5 10.5 149 237 
7 1472 39 F 10 10.5 122 305 
8 1384 48 M 11.5 11 131 299 
9 1764 27 F 11 11 102 238 
10 1735 60 M 13.5 12.5 160 405 
11 1994 55 F 13 13 149 376 
12 1838 48 F 12.5 12.5 158 399 
13 1807 31 F 10.5 10.5 121 301 
14 2086 39 M 12 11.5 107 310 
15 2279 40 F 11 11 113 298 
16 2680 52 F 12.5 12 138 334 
17 2877 32 M 11.5 11.5 102 294 
18 2991 57 F 12.5 12 141 301 
19 2673 50 F 12 12.5 132 398 
20 3095 46 M 11.5 11.5 115 299 
21 3041 49 M 11.5 11.5 120 364 
22 3562 52 M 11 11 103 382 
23 3992 60 F 13.5 13.5 137 401 
24 4773 37 F 11.5 11.5 99 222 
25 4710 53 F 13.5 13 119 368 
26 5002 58 F 12.5 12.5 156 438 
27 5348 43 F 11.5 11.5 150 290 
28 5791 46 M 12 12 148 375 
29 5899 59 F 12.5 12 168 502 
30 6302 39 F 10 10.5 143 376 
 xii 
 
31 6074 42 F 10.5 10.5 121 294 
32 6288 44 F 11 11 106 402 
33 6341 50 M 12 11.5 128 386 
34 6657 30 F 10.5 10.5 114 359 
35 6890 42 F 13 12 159 309 
36 7074 45 M 10.5 10.5 148 440 
37 7302 53 M 12.5 12.5 139 471 
38 7763 38 F 11.5 11.5 91 301 
39 7509 41 F 11 11 127 330 
40 7850 46 F 10.5 10.5 135 352 
41 8153 55 M 12 11.5 146 405 
42 8924 41 F 12.5 11.5 113 290 
43 8577 38 M 10.5 10.5 102 307 
44 9116 43 F 11.5 11.5 137 279 
45 9884 60 F 12.5 12 178 506 
46 9417 44 M 11.5 11.5 131 476 
47 9710 47 F 12.5 12.5 140 389 
48 10079 42 F 13.5 13 152 490 
49 10654 59 M 12.5 12.5 138 429 
50 11376 46 M 11.5 11.5 124 354 
 
